Tuberculosis Research Blood Bank
NCT00212498 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-12-09
Summary
To create a Tuberculosis Research Blood Bank for future molecular genetics and serological studies
Conditions
Interventions
- PROCEDURE
-
Develop a bank of blood samples from patients infected with TB for future molecular genetics studies and serological studies
Blood sample
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Rany Condos, MD · NYU School of Medicine
Eligibility
- Min Age
- 21 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2012-01-31
Countries
- United States
Study Locations
More Related Trials
-
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
NCT05621343 ·Status: RECRUITING
-
Tuberculosis in a Multiethnic Inner City Population
NCT00005379 ·Status: COMPLETED
-
Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
NCT02225158 ·Status: TERMINATED
-
Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study
NCT06019052 ·Status: NOT_YET_RECRUITING
-
Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment
NCT06845618 ·Status: RECRUITING
-
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
NCT01269268 ·Status: COMPLETED
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis
NCT01311999 ·Status: COMPLETED
-
Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis
NCT00173264 ·Status: UNKNOWN
-
Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term Dialysis
NCT01685086 ·Status: UNKNOWN
-
Identifcation of Biomarkers for Active Pulmonary Tuberculosis
NCT04490746 ·Status: UNKNOWN
-
Rapid Characterization of Paucibacillary TB Along Tex/Mex Border
NCT00421798 ·Status: COMPLETED
-
Serological Test for the Diagnosis of TB
NCT02898623 ·Status: TERMINATED
-
Point-of-care Triage Test for Active Tuberculosis
NCT04232618 ·Status: UNKNOWN
-
Rapid Research in Diagnostics Development for TB Network
NCT04923958 ·Status: RECRUITING ·Phase: NA
-
Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects
NCT04074369 ·Status: UNKNOWN
-
Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients
NCT05329415 ·Status: UNKNOWN
-
A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG
NCT01242475 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
NCT06728930 ·Status: ENROLLING_BY_INVITATION
-
Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level
NCT07170735 ·Status: RECRUITING
-
Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease
NCT05981495 ·Status: UNKNOWN
-
Clinical Evaluation of tNGS for Diagnosis of DR-TB
NCT04239326 ·Status: COMPLETED
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study
NCT05588492 ·Status: RECRUITING ·Phase: PHASE4
-
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
NCT06580639 ·Status: RECRUITING